Cellular Biomedicine Group Announces Three-Month Interim Safety Data from Phase I Clinical Trial for AlloJoinOff-the-Shelf Allogeneic Stem Cell... ...http://www.bizwireexpress.com/showstoryGNW.php?storyid=147375
From the Wires Dec. 9, 2016 07:45 AM LOS ANGELES, CA -- (Marketwired) -- 12/09/16 -- Stellar Biotechnologies, Inc. (NASDAQ: SBOT), a leading... ...http://in.sys-con.com/node/3969150
TOKYO (Reuters) - Principal Global Investors has upgraded its view on the U.S. economy and equities as it sees higher growth because of likely tax... ...https://in.news.yahoo.com/u-shares-most-attractive-recession-may-loom-principal-122709343--sector.html
The election of Donald Trump has sparked a lot of talk about inflation returning to the United States as a result of his protectionist trade... ...http://www.businessinsider.in/Bond-investors-shouldnt-drink-the-Kool-Aid-that-Wall-Streets-selling/articleshow/55883802.cms
The cumulative 175 basis point rate cut that has accrued since 2014 is finally getting transmitted to end users. You can now avail a home loan at... ...http://www.businessworld.in/article/Real-Estate-Wait-Watch/09-12-2016-109545
A Distribution House For Investment &...